BETA: Please send your feedback!
Momenta Pharmaceuticals
MNTA:NAS
Biotechnology
—
SMALL cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
About
Biotechnology
Founded 2001
Momenta Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products. It focuses on developing generic versions of complex drugs, biosimilars, and novel therapeutics for oncology and autoimmune disease. The company sells its products include Glatiramer acetate injection and Enoxaparin Sodium injection. Momenta Pharmaceuticals was founded by Ram Sasisekharan and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.
website
Headquarters
Executives
Name | Title | Gender |
Paul R. Schimmel, PhD | Founder | Male |
James R. Sulat, MBA | Chairman | Male |
Bruce A. Leicher | Secretary, Senior VP & General Counsel | Male |
Robert S. Langer, Jr., DSc | Founder | Male |
Craig A. Wheeler, MBA | President, Chief Executive Officer & Director | Male |
Christoph H. Westphal, MD, PhD | Founder | Male |
Ram Sasisekharan, PhD | Founder | Male |
Ganesh Venkataraman Kaundinya, PhD | Chief Scientific Officer & Senior VP-Research | Male |
Jo-Ann Beltramello | Senior Vice President-Human Resources | Female |
Sarah Carmody | Investor Relations Contact | Female |
Mallikarjun Sundaram, PhD, MBA | Founder | Male |
Scott M. Storer, MBA | Chief Financial Officer & Senior Vice President | Male |
Mindful Investing Summary
Momenta Pharmaceuticals - Competitors and Related Companies
How Momenta Pharmaceuticals stacks up to its peers in the Biotechnology industry or with competing business segments.
Momenta Pharmaceuticals
MNTA:NAS
Biotechnology
—
SMALL cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 2
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Pacira Pharmaceuticals
PCRX:NAS
Pharmaceuticals: Other
—
SMALL cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Baxter International
BAX:NYS
Medical Specialties
—
LARGE cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Biogen
BIIB:NAS
Biotechnology
—
MEGA cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 3
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Johnson & Johnson
JNJ:NYS
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Pfizer
PFE:NYS
Pharmaceuticals: Major
—
MEGA cap
(—)
—
since start of 2021
—
- 3
- 3
- 1
- —
- —
- 1
- 4
- 3
- —
- —
- —
- 4
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership